We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
AUM
$77.1M
AUM Growth
+$496K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
8
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FATE icon
1
Fate Therapeutics
FATE
$291M
$47M 60.92%
569,889
LYRA
2
DELISTED
LYRA THERAPEUTICS INC
LYRA
$12.8M 16.54%
22,017
RNAC icon
3
Cartesian Therapeutics
RNAC
$231M
$12.6M 16.27%
92,449
XFOR icon
4
X4 Pharmaceuticals
XFOR
$386M
$2.68M 3.48%
10,383
ATYR
5
aTyr Pharma
ATYR
$48.2M
$581K 0.75%
130,572
DARE icon
6
Dare Bioscience
DARE
$19.2M
$551K 0.71%
27,187
GNCA
7
DELISTED
Genocea Biosciences, Inc.
GNCA
$535K 0.69%
197,345
PULM icon
8
Pulmatrix
PULM
$6.35M
$478K 0.62%
17,972

Similar funds

Polaris Venture Management Co V's Q1 2021 Portfolio in Review

As of Q1 2021, Polaris Venture Management Co V held 8 positions worth $77.1M, up 0.65% from $76.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2021: portfolio turnover was 0%. Polaris Venture Management Co V opened no new positions and made no exits, leaving the 8-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Polaris Venture Management Co V's ten largest holdings make up 100% of its $77.1M portfolio in Q1 2021.
  • Polaris Venture Management Co V opened 0 new positions and closed 0 in Q1 2021.
  • Polaris Venture Management Co V's portfolio value rose 0.65% quarter-over-quarter to $77.1M.

Based on Polaris Venture Management Co V's 13F filing for Q1 2021, filed 12 May 2021.